Cargando…
Activity of a new nitrosourea (TCNU) in human lung cancer xenografts.
The activity of a new nitrosourea (TCNU) based on the endogenous amino acid taurine was assessed in three human lung cancer xenografts growing in immunodeficient mice. Moderate activity (specific growth delays of 0.63 and 1.13 compared with controls) was seen in two non-small cell tumours after a si...
Autores principales: | Fergusson, R. J., Anderson, L. E., Macpherson, J. S., Robins, P., Smyth, J. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246564/ https://www.ncbi.nlm.nih.gov/pubmed/3390369 |
Ejemplares similares
-
Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.
por: Bibby, M. C., et al.
Publicado: (1992) -
O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines.
por: Walker, M. C., et al.
Publicado: (1992) -
Proceedings: Mechanism of action of tumour inhibitory nitrosoureas.
por: Connors, T. A., et al.
Publicado: (1975) -
Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferon.
por: Langdon, S. P., et al.
Publicado: (1991) -
Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.
por: Pujol, J. L., et al.
Publicado: (1994)